- Products
- Injection and oral disintegrating tablet
- Monthly injection offer
- $109 first month; $219/month afterward in the monthly presentation
- Cancellation
- Timing relative to pharmacy transfer matters
Two products require two comparisons
System Labs markets compounded sermorelin in an injectable preparation and an oral disintegrating tablet. They have separate product pages and starting offers. This guide reviews each individually because route, formulation and evidence should not disappear into one provider-level price. An oral option is not automatically interchangeable with an injection simply because both contain the same named peptide.
The provider describes an online assessment followed by prescribing and pharmacy fulfillment when appropriate. We have not completed that assessment or tested the service. Public pages establish the advertised pathway, while the actual clinician, pharmacy, eligibility decision and prescription still need confirmation for an individual applicant.
Identify the term behind the introduction
The injection page's monthly offer describes $109 for the first month and $219 per month afterward. Other rendered selections showed different introductory and reference prices connected with a quarterly presentation. Those differences make the chosen purchase term important: a monthly promotion should not be combined with a quarterly quantity to create a synthetic bargain.
The oral page displayed a $79 first-month figure alongside a $159 reference amount. A reference price does not necessarily identify the next charge or the full first invoice. Ask for a dated payment schedule for the selected formulation and term, including any prepaid commitment, rather than projecting a year from the lowest visible opening price.
Cancellation depends on order progress
System Labs' terms distinguish cancellation before a prescription is sent to the partner pharmacy from later fulfillment stages. They describe no charge, with an authorization hold released, when cancellation occurs before that transfer. Orders already processed or shipped generally do not qualify for ordinary returns under the reviewed policy.
The terms also describe a seven-day reporting window for an incorrect or damaged order, with replacement handled under the company's conditions. That is a separate process from deciding to stop a subscription. Clarify when a refill becomes an active pharmacy order and obtain confirmation that future renewal has been stopped if the plan is cancelled.
Convenience does not establish clinical equivalence
The site advertises delivery and ongoing access to care. Confirm whether required laboratory work, all consultations and supplies are included in the selected quote, and how medical questions are escalated after receipt. Delivery speed and a simple intake process are service features; they do not demonstrate a treatment effect or substitute for appropriate monitoring.
Both product assessments retain the distinction between a compounded prescription and an FDA-approved medication. Ask the clinician what human evidence supports the particular route and intended use. The strongest purchasing comparison here is one that preserves the actual formulation, payment term and pharmacy-transfer deadline, rather than reducing two different offers to one promotional monthly number.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.